3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

424B5 - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

Wuxi, China, July 06, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America, and the cross-border store has been officially approved for opening and all registration procedures have been completed. This successful entry represents a critical milestone in the execution of the Company's global expansion strategy, reflecting the Amazon platform’s authoritative recognition of Park Ha Biological’s overall brand strength, core product competitiveness, and standardized operational excellence. As the world's lead

Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that it has formally filed a complete membership application with the Personal Care Products Council (PCPC). The submission encompasses all requisite corporate qualifications, raw material compliance documentation, and product safety materials, all of which are currently under review. This application marks a pivotal step in establishing the Company’s comprehensive compliance framework for the North American market, facilitating its planned entry into Amazon’s North America marketplace, and securing access to the technical, regulatory, and i

Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced significant progress in its global expansion by initiating cooperation with Amazon ("Amazon") North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business. Currently, four key tasks are advancing concurrently: store qualification registration, Amazon brand registry enrollment, establishment of a compliance framework for the North American market, and planning of localized product operation strategies. All preparatory e

Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong ("Cloud Factory"). The two parties will jointly develop a specialized AI-driven ecosystem tailored for the beauty industry, leveraging cross-domain technological collaboration to transcend traditional growth limitations in the sector and usher in a new era of AI-powered, lean operations. The traditional offline beauty business model has long faced widespread op

Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ:BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the "Class A Ordinary Shares"), and pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant. The gross proceeds to the Co

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ:BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the "Offering") consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the "Shares"), and pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 200,000 Class A ordinary shares (the "Warrant Shares"), at a combined purchase price of $1.50 per Share and Pre-Funded

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that the Company has established a comprehensive strategic partnership with Star Plus Action (HK) Limited ("Star Plus Action"), a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), a company listed on The Stock Exchange of Hong Kong ("Star Plus Legend"). The two parties will integrate resources in the healthcare industry, skincare product development, celebrity IP management, and artificial intelligence technology to jointly advance the beauty and wellness sector, creating an innovative business model that combines AI t

Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) (the "Company") today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a "Unit") at an offering price of US$0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a "Class A Ordinary Share") and one warrant to purchase one Class A Ordinary Share, or up to nine Class A Ordinary Shares pursuant to the alternative cashless exercise mechanism described therein (each, a "Warrant"). Each Warrant has an exercise price of US$0.112 per Class A Ordinary Share and is exercisable beginning on th

Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) (the "Company") today announced the pricing of a best-efforts follow-on public offering of 21,875,000 units (each a "Unit") at an offering price of US$0.112  per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a "Class A Ordinary Share") and one warrant to purchase one Class A Ordinary Share (or up to nine Class A Ordinary Shares pursuant to the zero exercise price option)  (each, a "Warrant"). Each Warrant will have an exercise price of US$0.112 per Class A Ordinary Share and will be exercisable beginning on the issuance date a